Patrice Morand

4.7k total citations
139 papers, 2.7k citations indexed

About

Patrice Morand is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Patrice Morand has authored 139 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 61 papers in Infectious Diseases and 54 papers in Oncology. Recurrent topics in Patrice Morand's work include Viral-associated cancers and disorders (50 papers), Cytomegalovirus and herpesvirus research (32 papers) and Parvovirus B19 Infection Studies (29 papers). Patrice Morand is often cited by papers focused on Viral-associated cancers and disorders (50 papers), Cytomegalovirus and herpesvirus research (32 papers) and Parvovirus B19 Infection Studies (29 papers). Patrice Morand collaborates with scholars based in France, United Kingdom and United States. Patrice Morand's co-authors include Marc Conti, Alban Le Monnier, P Levillain, J.‐P. Stahl, Jean‐Marie Seigneurin, Julien Lupo, Raphaële Germi, Alexandra Mailles, O. Genoulaz and Samira Fafi‐Kremer and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and PLoS ONE.

In The Last Decade

Patrice Morand

135 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrice Morand France 29 1.2k 914 874 390 368 139 2.7k
Noriko Nakajima Japan 31 1.2k 1.0× 977 1.1× 543 0.6× 186 0.5× 106 0.3× 131 3.5k
Pierluca Piselli Italy 28 831 0.7× 402 0.4× 698 0.8× 230 0.6× 158 0.4× 105 2.3k
Francisco Díaz‐Mitoma Canada 32 1.4k 1.1× 697 0.8× 437 0.5× 306 0.8× 176 0.5× 138 3.4k
Jinjong Myoung South Korea 24 882 0.7× 956 1.0× 943 1.1× 117 0.3× 128 0.3× 60 2.5k
Laura W. Lamps United States 27 640 0.5× 361 0.4× 432 0.5× 237 0.6× 146 0.4× 102 2.8k
Édouard Tuaillon France 30 1.3k 1.1× 1.3k 1.4× 217 0.2× 555 1.4× 74 0.2× 147 2.9k
Donald D. Anthony United States 36 756 0.6× 632 0.7× 433 0.5× 580 1.5× 250 0.7× 128 3.9k
Howard S. Jaffe United States 30 1.4k 1.2× 854 0.9× 716 0.8× 166 0.4× 141 0.4× 39 3.4k
Hiroyuki Tsutsumi Japan 30 1.5k 1.3× 1.1k 1.2× 353 0.4× 134 0.3× 118 0.3× 206 3.4k
Suranjith L. Seneviratne United Kingdom 27 705 0.6× 1.1k 1.2× 188 0.2× 364 0.9× 94 0.3× 108 3.2k

Countries citing papers authored by Patrice Morand

Since Specialization
Citations

This map shows the geographic impact of Patrice Morand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Morand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Morand more than expected).

Fields of papers citing papers by Patrice Morand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice Morand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Morand. The network helps show where Patrice Morand may publish in the future.

Co-authorship network of co-authors of Patrice Morand

This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Morand. A scholar is included among the top collaborators of Patrice Morand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Morand. Patrice Morand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morand, Patrice, et al.. (2025). Impact of tacrolimus on interferon gamma ELISpot assay results for the assessment of T-cell immunity: Proof-of-concept. International Journal of Immunopathology and Pharmacology. 39. 1220545158–1220545158.
2.
Bally, Isabelle, Marlyse Buisson, Raphaële Germi, et al.. (2024). Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants. Microbiology Spectrum. 13(1). e0156824–e0156824. 2 indexed citations
3.
Peuchmaur, Marine, Mathieu Vaillant, Julien Lupo, et al.. (2023). Epstein-Barr Virus Encephalitis: A Review of Case Reports from the Last 25 Years. Microorganisms. 11(12). 2825–2825. 7 indexed citations
4.
Noble, Johan, Anaïs Dartevel, Céline Dard, et al.. (2023). Fatal HSV-2 primary infection most likely acquired by kidney transplantation: A case report. International Journal of Antimicrobial Agents. 61(5). 106769–106769. 1 indexed citations
7.
Günther, Johannes, Alexander Buschle, Christine Göbel, et al.. (2021). Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1. Nucleic Acids Research. 50(1). 490–511. 17 indexed citations
8.
Trémeaux, Pauline, Christophe Ramière, Nicolas Tarbouriech, et al.. (2016). Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains. Clinical Microbiology and Infection. 22(5). 460.e1–460.e10. 6 indexed citations
9.
Lupo, Julien, et al.. (2015). Fatal case of acute gastroenteritis with multiple viral coinfections. Journal of Clinical Virology. 74. 54–56. 2 indexed citations
10.
Gillois, Pierre, et al.. (2015). Les clefs de la réussite à Grenoble aux Épreuves classantes nationales : les formations intégrées hospitalo-universitaire. La Presse Médicale. 44(12). e353–e361. 3 indexed citations
11.
Gratacap-Cavallier, B., et al.. (2011). Occupational risk for cytomegalovirus, but not for parvovirus B19 in child-care personnel in France. Journal of Infection. 63(6). 457–467. 13 indexed citations
12.
Gruffat, Henri, Julien Lupo, Patrice Morand, Véronique Boyer, & Évelyne Manet. (2010). The Nuclear and Adherent Junction Complex Component Protein Ubinuclein Negatively Regulates the Productive Cycle of Epstein-Barr Virus in Epithelial Cells. Journal of Virology. 85(2). 784–794. 7 indexed citations
13.
Salameire, Dimitri, Rémy Gressin, Patrice Morand, et al.. (2008). Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome. Scandinavian Journal of Infectious Diseases. 40(4). 343–346. 14 indexed citations
14.
Malvy, Denis, Khaled Ezzedine, Bruno Halioua, et al.. (2007). Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study. Journal of the European Academy of Dermatology and Venereology. 21(10). 1398–1403. 18 indexed citations
15.
Bani‐Sadr, Firouzé, Fabrice Carrat, Stanislas Pol, et al.. (2005). Risk Factors for Symptomatic Mitochondrial Toxicity in HIV/Hepatitis C Virus-Coinfected Patients During Interferon Plus Ribavirin-Based Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(1). 47–52. 64 indexed citations
16.
Chanzy, B., et al.. (2002). Débats et actualités dans le diagnostic virologique de l’herpès. Pathologie Biologie. 50(7). 419–424. 2 indexed citations
19.
Guillon, Christophe, et al.. (1994). Blood Monocytes Infected In Vivo by HIV-1 Variants with a Syncytium-Inducing Phenotype. AIDS Research and Human Retroviruses. 10(6). 683–690. 15 indexed citations
20.
Ottmann, Michèle, et al.. (1992). HIV-1 in Blood Monocytes: Frequency of Detection of Proviral DNA Using PCR and Comparison with the Total CD4 Count. AIDS Research and Human Retroviruses. 8(2). 261–268. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026